GPCR News and Research

RSS
New international consortium to advance GPCR research for drug development

New international consortium to advance GPCR research for drug development

Internal water channels can pave way for novel approaches in drug development

Internal water channels can pave way for novel approaches in drug development

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena's Phase 1b data for TRV130 published in the journal Pain

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

Understanding GPCRs and controlling inflammation: an interview with Dr. Richard Proia, NIDDK, NIH

Understanding GPCRs and controlling inflammation: an interview with Dr. Richard Proia, NIDDK, NIH

RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

Two new risk loci for bipolar disorder identified

Two new risk loci for bipolar disorder identified

Monash University research offers new hope to people with heart attacks

Monash University research offers new hope to people with heart attacks

Photoreactive compounds open new routes to treatment of neurological diseases

Photoreactive compounds open new routes to treatment of neurological diseases

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Trevena prices initial public offering of common stock

Trevena prices initial public offering of common stock

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Unprecedented, atom-scale simulation of G protein-coupled receptor site's transformation

Unprecedented, atom-scale simulation of G protein-coupled receptor site's transformation

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Brain & Behavior Research Foundation to hold research symposium on mental health

Brain & Behavior Research Foundation to hold research symposium on mental health

Nuevolution forms scientific collaboration to investigate biological mechanism of GPCR drug target

Nuevolution forms scientific collaboration to investigate biological mechanism of GPCR drug target

Omeros announces financial results for second quarter of 2013

Omeros announces financial results for second quarter of 2013

TSRI scientists study 3-D structure of glucagon receptor for treatment of diabetes

TSRI scientists study 3-D structure of glucagon receptor for treatment of diabetes